Core Scientific CORZ
$11.33 −$2.03 (-15.19%)
Market closed · Nov 22, 5:30 am ET · Last extended-hours $11.75 +3.74%
Open$12.93
Prev close$13.36
Day range$11.26 – $12.99
Volume22.28M
Market cap$3.65B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$232.87M+187.1% YoY
Operating profit$79.21M+245.4% YoY
Net profit$1.18B+918.0% YoY
Diluted EPS$0.47+204.4% YoY
Free cash flow-$475.44M-321.8% YoY
Operating cash flow$65.29M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin41.2%
Operating margin-11.4%
Net margin-20.1%
Return on assets-2.9%
Current ratio0.67
Liabilities / assets118.4%
Cash & investments$803.94M
Total debt$4.30B
Net cash (debt)-$3.50B
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $232.87M | $164.20M | $115.24M | $319.02M | $79.76M |
| Total Operating Revenue | $232.87M | $164.20M | $115.24M | $319.02M | $79.76M |
| Cost of Revenue | $109.59M | $94.16M | $85.14M | $281.12M | $59.01M |
| Gross Profit | $123.27M | $70.04M | $30.11M | $37.90M | $20.76M |
| Operating Expense | $44.06M | $85.80M | $60.40M | $262.45M | $121.66M |
| Selling and Admin Expenses | $50.39M | $49.39M | $45.18M | $182.60M | $51.24M |
| -General & Admin Expense | $50.39M | – | $45.18M | $182.60M | $51.24M |
| Other Operating Expenses | -$6.33M | $36.41M | $15.22M | $79.85M | $70.42M |
| Operating Profit | $79.21M | -$15.75M | -$30.30M | -$224.55M | -$100.91M |
| Net Non-Operating Interest Income (Expense) | -$35.05M | -$23.83M | -$4.86M | $3.28M | -$916,000.00 |
| Total Other Finance Costs | $35.05M | $23.83M | – | – | – |
| Other Income (Expense) | $1.03B | -$1.11B | -$311.44M | -$66.76M | $317.88M |
| Gain on Sale of Security | $1.03B | -$1.05B | -$30.80M | -$33.06M | $330.30M |
| Special Income (Charges) | -$6.86M | -$68.15M | -$280.63M | -$33.66M | -$12.31M |
| -Less:Impairment of Capital Assets | $1.52M | $19.50M | $266.49M | $11.36M | $11.36M |
| -Gain on Sale of Property/Plant/Equipment | -$5.34M | -$1.27M | -$13.64M | -$9.68M | -$5.21M |
| Other Non-Operating Income (Expenses) | -$37,000.00 | -$152,000.00 | -$10,000.00 | -$39,000.00 | -$112,000.00 |
| Pretax Profit | $1.07B | -$1.15B | -$346.59M | -$288.03M | $216.05M |
| Tax | -$106.51M | $1.91M | $600,000.00 | $583,000.00 | $95,000.00 |
| Net Profit | $1.18B | -$1.16B | -$347.19M | -$288.62M | $215.96M |
| Profit from Continuing Operations | $1.18B | -$1.16B | -$347.19M | -$288.62M | $215.96M |
| Net Income to Parent Company | $1.18B | -$1.16B | -$347.19M | -$288.62M | $215.96M |
| Other Preferred Stock Dividends | $56.16M | -$74.23M | -$4.75M | – | – |
| Net Income to Common Stockholders | $1.12B | -$1.08B | -$342.44M | -$288.62M | $182.65M |
| Basic EPS | $3.42 | -$3.32 | -$1.06 | -$0.88 | $0.60 |
| Diluted EPS | $0.47 | -$3.32 | -$1.06 | -$0.88 | $0.42 |
| -Less:Other Special Charges | – | $47.38M | $500,000.00 | $12.62M | -$4.26M |
| Non-Operating Interest Expense | – | – | $4.86M | – | – |
| Non-Operating Interest Income | – | – | – | $3.28M | -$916,000.00 |
| -Less:Restructuring and Mergern & Acquisition | – | – | – | $0.00 | $0.00 |
| -Less:Write Off | – | – | – | $0.00 | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $5.94B | $5.26B | $3.07B | $2.35B | $2.35B |
| Total Current Assets | $1.42B | $2.44B | $1.45B | $895.54M | $895.54M |
| Cash and Cash Equivalents & Short-Term Investments | $803.94M | $1.77B | $1.01B | $311.38M | $311.38M |
| -Cash and Cash Equivalents | $803.94M | $1.77B | $1.01B | $311.38M | $311.38M |
| Receivables | $282.66M | $383.76M | $315.67M | $337.16M | $337.16M |
| -Other Receivables | $282.66M | – | $315.67M | – | – |
| Prepaid Assets | $34.94M | – | – | – | – |
| Restricted Cash | $201.75M | $165.75M | $60.24M | $0.00 | $0.00 |
| Other Current Assets | $69.16M | $124.41M | $73.77M | $247.00M | $247.00M |
| Total Non-Current Assets | $4.51B | $2.81B | $1.61B | $1.45B | $1.45B |
| Net PPE | $2.74B | $1.89B | $1.45B | $1.40B | $1.40B |
| -Gross PPE | $2.81B | $2.26B | $1.82B | $1.81B | $1.81B |
| -Accumulated Depreciation | -$72.81M | -$371.26M | -$372.19M | -$406.89M | -$406.89M |
| Goodwill and Other Intangible Assets | $737.53M | $228.63M | – | – | – |
| -Other Intangible Assets | $737.53M | $228.63M | – | – | – |
| Non-Current Deferred Assets | $295.00M | – | – | – | – |
| Other Non-Current Assets | $740.18M | $696.88M | $163.82M | $48.48M | $48.48M |
| Total Liabilities | $7.03B | $7.68B | $4.38B | $3.31B | $3.31B |
| Total Current Liabilities | $2.11B | $2.74B | $2.66B | $781.40M | $781.40M |
| Payables | $120.88M | $112.37M | $218.86M | $126.11M | $126.11M |
| -Accounts Payable | $120.88M | $112.37M | $218.86M | $126.11M | $126.11M |
| Current Accrued Expenses | $779.52M | $509.19M | $364.48M | $511.96M | $511.96M |
| Current Deferred Liabilities | $309.07M | $287.20M | $219.56M | $127.56M | $127.56M |
| Other Current Liabilities | $897.75M | $1.83B | $864.95M | $3.43M | $3.43M |
| Total Non-Current Liabilities | $4.92B | $4.94B | $1.71B | $2.53B | $2.53B |
| Long Term Debt and Capital Lease Obligation | $4.30B | $4.30B | $1.06B | $1.15B | $1.15B |
| -Long Term Debt | $4.30B | $4.30B | $1.06B | $1.06B | $1.06B |
| Derivative Product Liabilities | $238.18M | $163.68M | $116.50M | $936.11M | $936.11M |
| Non-Current Deferred Liabilities | $264.51M | $367.24M | $434.67M | $428.29M | $428.29M |
| Other Non-Current Liabilities | $115.72M | $110.16M | $100.65M | $14.41M | $14.41M |
| Total Equity | -$1.09B | -$2.42B | -$1.31B | -$962.74M | -$962.74M |
| Stockholders' Equity | -$1.09B | -$2.42B | -$1.31B | -$962.74M | -$962.74M |
| Capital Stock | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 |
| -Common Stock | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $3.38B | $3.23B | $3.19B | $3.18B | $3.18B |
| Retained Earnings | -$4.47B | -$5.65B | -$4.49B | -$4.15B | -$4.15B |
| -Accounts Receivable | – | $383.76M | – | $337.16M | $337.16M |
| Short-Term Debt and Capital Lease Obligation | – | – | $993.94M | $12.34M | $12.34M |
| -Current Debt | – | – | $993.94M | – | – |
| -Current Capital Lease Obligation | – | – | – | $12.34M | $12.34M |
| -Long Term Capital Lease Obligation | – | – | – | $89.86M | $89.86M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $65.29M | -$18.93M | $249.88M | $278.25M | $157.51M |
| Net cash flow from continuing operations | $65.29M | -$18.93M | $249.88M | $278.25M | $157.51M |
| Net Income from Continuing Operations | $1.18B | -$1.16B | -$347.19M | -$288.62M | $215.96M |
| Gain/Loss from Continuing Operations | -$1.01B | $1.06B | $52.03M | $45.58M | -$331.88M |
| Depreciation & Depletion & Amortization | $11.59M | $18.73M | $19.82M | $80.18M | $25.36M |
| Other Non-Cash Items | $20.15M | -$2.67M | $178.77M | -$193.02M | $24.44M |
| Change in Working Capital | -$50.06M | $41.52M | $62.20M | $524.53M | $184.33M |
| -Change in Receivables | $136.34M | – | – | $0.00 | $335.64M |
| -Change in Payables and Accrued Expense | -$34.66M | $130.09M | -$10.49M | -$6.62M | -$357.21M |
| -Change In Other Working Capital | -$100.76M | $3.38M | $62.58M | $514.93M | $201.17M |
| Net cash flow from investing | -$983.02M | -$796.24M | -$386.65M | -$740.75M | -$277.77M |
| Net Cash Flow from Continuing Investing Activities | -$983.02M | -$796.24M | -$386.65M | -$740.75M | -$277.77M |
| Net PPE Purchase and Sale | -$538.57M | -$563.72M | -$386.60M | -$725.54M | -$277.72M |
| Net Other Investing Changes | -$75,000.00 | – | – | – | – |
| Financing Cash Flow | $7.88M | $2.22B | $971.38M | -$63.10M | -$21.81M |
| Net Cash Flow from Continuing Financing Activities | $7.88M | $2.22B | $971.38M | -$63.10M | -$21.81M |
| Net Issuance Payments Of Debt | $0.00 | $3.28B | $993.91M | -$10.29M | -$1.67M |
| Net Other Financing Charges | -$3.86M | -$1.06B | -$22.60M | -$59.73M | -$25.30M |
| Ending Cash Balance | $1.64B | $2.55B | $1.15B | $311.38M | $311.38M |
| Net Change in Cash | -$909.85M | $1.41B | $834.61M | -$525.60M | -$142.07M |
| Beginning Cash Balance | $2.55B | $1.15B | $311.38M | $836.98M | $453.44M |
| Free Cash Flow | -$475.44M | -$583.89M | -$139.40M | -$460.96M | -$131.95M |
| -Change in Prepaid Assets | – | – | $10.11M | $16.22M | – |
| Net Intangibles Purchase and Sale | – | – | -$55,000.00 | -$10.21M | – |
| Net Business Purchase and Sale | – | – | $0.00 | -$5.00M | -$5.00M |
| Proceeds from Stock Option Exercised | – | – | $81,000.00 | $6.91M | $5.17M |
| Net Common Stock Issuance | – | – | – | $0.00 | $0.00 |
No comments yet — be the first to weigh in on CORZ.
Sign in to join the discussion.